Neuronetics, Inc. (STIM)
NASDAQ: STIM · IEX Real-Time Price · USD
1.925
+0.025 (1.32%)
At close: Jul 19, 2024, 4:00 PM
1.910
-0.015 (-0.78%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Neuronetics Revenue

Neuronetics had revenue of $73.23M in the twelve months ending March 31, 2024, with 10.01% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $17.42M with 12.08% year-over-year growth. In the year 2023, Neuronetics had annual revenue of $71.35M with 9.42% growth.

Revenue (ttm)
$73.23M
Revenue Growth
+10.01%
P/S Ratio
0.79
Revenue / Employee
$360,714
Employees
203
Market Cap
57.75M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202371.35M6.14M9.42%
Dec 31, 202265.21M9.89M17.89%
Dec 31, 202155.31M6.07M12.32%
Dec 31, 202049.24M-13.41M-21.41%
Dec 31, 201962.66M9.88M18.72%
Dec 31, 201852.78M12.34M30.53%
Dec 31, 201740.43M6.21M18.13%
Dec 31, 201634.23M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Rockwell Medical 86.62M
LENSAR 44.50M
Cytosorbents 36.69M
Cryo-Cell International 31.64M
CollPlant Biotechnologies 10.62M
Adlai Nortye 5.00M
Enzo Biochem 4.72M
Revenue Rankings